Kurt Zimmermann

2.7k total citations
66 papers, 1.7k citations indexed

About

Kurt Zimmermann is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kurt Zimmermann has authored 66 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 18 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kurt Zimmermann's work include Radiopharmaceutical Chemistry and Applications (15 papers), Probiotics and Fermented Foods (11 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Kurt Zimmermann is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (15 papers), Probiotics and Fermented Foods (11 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Kurt Zimmermann collaborates with scholars based in Germany, Switzerland and United States. Kurt Zimmermann's co-authors include Jürgen Grünberg, Michael Honer, P. August Schubiger, Ilse Novak‐Hofer, Roger Schibli, Simone Jeger, Alain Blanc, Peter Hunziker, Harriet Struthers and Simon M. Ametamey and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Kurt Zimmermann

66 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt Zimmermann Germany 24 780 607 347 342 202 66 1.7k
Djuro Josić United States 28 1.9k 2.4× 595 1.0× 78 0.2× 133 0.4× 113 0.6× 96 2.7k
Sandeep Nema United States 14 1.7k 2.1× 837 1.4× 69 0.2× 192 0.6× 49 0.2× 23 2.2k
Christopher Kirby United Kingdom 18 1.0k 1.3× 124 0.2× 106 0.3× 197 0.6× 133 0.7× 28 1.8k
Steffen Goletz Germany 25 1.3k 1.6× 646 1.1× 343 1.0× 100 0.3× 229 1.1× 69 1.7k
Karina V. Mariño Argentina 24 1.4k 1.8× 171 0.3× 216 0.6× 119 0.3× 426 2.1× 63 2.2k
An Aerts Belgium 29 1.1k 1.4× 760 1.3× 272 0.8× 45 0.1× 71 0.4× 50 2.2k
Martin Empting Germany 29 1.6k 2.0× 451 0.7× 182 0.5× 32 0.1× 435 2.2× 78 2.2k
Peter E. Andreotti United States 21 602 0.8× 151 0.2× 479 1.4× 43 0.1× 73 0.4× 37 1.6k
Michael Hornsby United States 16 795 1.0× 162 0.3× 156 0.4× 165 0.5× 384 1.9× 18 1.4k
Osamu Ando Japan 22 691 0.9× 81 0.1× 416 1.2× 75 0.2× 164 0.8× 62 1.6k

Countries citing papers authored by Kurt Zimmermann

Since Specialization
Citations

This map shows the geographic impact of Kurt Zimmermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Zimmermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Zimmermann more than expected).

Fields of papers citing papers by Kurt Zimmermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Zimmermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Zimmermann. The network helps show where Kurt Zimmermann may publish in the future.

Co-authorship network of co-authors of Kurt Zimmermann

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Zimmermann. A scholar is included among the top collaborators of Kurt Zimmermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Zimmermann. Kurt Zimmermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hickey, Christopher M., Katherine M. Digianantonio, Kurt Zimmermann, et al.. (2024). Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules. Nature Structural & Molecular Biology. 31(2). 311–322. 29 indexed citations
2.
Schaefer, Michael, Kurt Zimmermann, & Paul Enck. (2023). A randomized controlled trial of effects of open-label placebo compared to double-blind placebo and treatment-as-usual on symptoms of allergic rhinitis. Scientific Reports. 13(1). 8372–8372. 6 indexed citations
3.
Rahmani, Maryam, et al.. (2022). Enterococci as Intestinal Microbiota: Investigation of Characteristics and Probiotic Potential in Isolates from Adults and Breast-Fed Infants. Probiotics and Antimicrobial Proteins. 14(6). 1139–1150. 3 indexed citations
4.
Dong, Hanqing, et al.. (2021). Evaluating Ligands for Ubiquitin Ligases Using Affinity Beads. Methods in molecular biology. 2365. 59–75. 1 indexed citations
5.
Baccouri, Olfa, Amine M. Boukerb, Kurt Zimmermann, et al.. (2019). Probiotic Potential and Safety Evaluation of Enterococcus faecalis OB14 and OB15, Isolated From Traditional Tunisian Testouri Cheese and Rigouta, Using Physiological and Genomic Analysis. Frontiers in Microbiology. 10. 881–881. 82 indexed citations
6.
7.
Klein, Günter, et al.. (2013). Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products. PLoS ONE. 8(6). e66682–e66682. 21 indexed citations
8.
Grünberg, Jürgen, Simone Jeger, Dikran Sarko, et al.. (2013). DOTA-Functionalized Polylysine: A High Number of DOTA Chelates Positively Influences the Biodistribution of Enzymatic Conjugated Anti-Tumor Antibody chCE7agl. PLoS ONE. 8(4). e60350–e60350. 25 indexed citations
9.
Fischer, Eliane, Jürgen Grünberg, Susan Cohrs, et al.. (2011). L1‐CAM‐targeted antibody therapy and 177Lu‐radioimmunotherapy of disseminated ovarian cancer. International Journal of Cancer. 130(11). 2715–2721. 29 indexed citations
10.
Velaparthi, Upender, Mark G. Saulnier, Mark D. Wittman, et al.. (2010). Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one. Bioorganic & Medicinal Chemistry Letters. 20(10). 3182–3185. 16 indexed citations
11.
Höhn, Alexander, et al.. (2008). Production and separation of ''non-standard'' PET nuclides at a large cyclotron facility: the experiences at the Paul Scherrer Institute in Switzerland.. PubMed. 52(2). 145–50. 26 indexed citations
12.
Saulnier, Mark G., David B. Frennesson, Mark D. Wittman, et al.. (2008). 2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924. Bioorganic & Medicinal Chemistry Letters. 18(5). 1702–1707. 20 indexed citations
13.
Zimmermann, Kurt, Mark D. Wittman, Mark G. Saulnier, et al.. (2008). Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4075–4080. 17 indexed citations
14.
Domann, Eugen, Torsten Hain, Rohit Ghai, et al.. (2007). Comparative genomic analysis for the presence of potential enterococcal virulence factors in the probiotic Enterococcus faecalis strain Symbioflor 1. International Journal of Medical Microbiology. 297(7-8). 533–539. 91 indexed citations
15.
Velaparthi, Upender, Mark D. Wittman, Peiying Liu, et al.. (2007). Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R). Bioorganic & Medicinal Chemistry Letters. 17(8). 2317–2321. 35 indexed citations
16.
17.
Novak‐Hofer, Ilse, Robert Waibel, Kurt Zimmermann, et al.. (2004). Radiometal Labeling of Antibodies and Antibody Fragments for Imaging and Therapy. Humana Press eBooks. 248. 481–494. 4 indexed citations
18.
Novak‐Hofer, Ilse, Michael Honer, Simon M. Ametamey, et al.. (2003). Imaging of renal carcinoma xenografts with 64 Cu-labelled anti-L1-CAM antibody chCE7. European Journal of Nuclear Medicine and Molecular Imaging. 30(7). 1066–1066. 3 indexed citations
19.
Novak‐Hofer, Ilse, Kurt Zimmermann, & P. August Schubiger. (2001). Peptide Linkers Lead to Modification of Liver Metabolism and Improved Tumor Targeting of Copper-67-labeled Antibody Fragments. Cancer Biotherapy and Radiopharmaceuticals. 16(6). 469–481. 10 indexed citations
20.
Zimmermann, Kurt, et al.. (1995). Development of a simple and selective separation of 67Cu from irradiated zinc for use in antibody labelling: A comparison of methods. Applied Radiation and Isotopes. 46(5). 329–336. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Djuro Josić Breakdown of academic impact, for papers by Sandeep Nema Breakdown of academic impact, for papers by Christopher Kirby Breakdown of academic impact, for papers by Steffen Goletz Breakdown of academic impact, for papers by Karina V. Mariño Breakdown of academic impact, for papers by An Aerts Breakdown of academic impact, for papers by Martin Empting Breakdown of academic impact, for papers by Peter E. Andreotti Breakdown of academic impact, for papers by Michael Hornsby Breakdown of academic impact, for papers by Osamu Ando
Rankless by CCL
2026